{"id":205568,"date":"2025-02-05T06:24:22","date_gmt":"2025-02-05T12:24:22","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/02\/incident-schizophrenia-and-cannabis-use-disorder-after-cannabis-legalization"},"modified":"2025-02-05T06:24:22","modified_gmt":"2025-02-05T12:24:22","slug":"incident-schizophrenia-and-cannabis-use-disorder-after-cannabis-legalization","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/02\/incident-schizophrenia-and-cannabis-use-disorder-after-cannabis-legalization","title":{"rendered":"Incident Schizophrenia and Cannabis Use Disorder After Cannabis Legalization"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/incident-schizophrenia-and-cannabis-use-disorder-after-cannabis-legalization.png\"><\/a><\/p>\n<p>Question Were the liberalization of medical cannabis and the legalization of nonmedical cannabis in Canada associated with changes in the population-attributable fraction of cannabis use disorders associated with <i>schizophrenia<\/i>?<\/p>\n<p><strong>Findings<\/strong> In this population-based cohort study comprising 13 588 681 individuals, the population-attributable fraction of cannabis use disorder associated with <i>schizophrenia<\/i> increased significantly from 3.7% in the prelegalization period to 10.3% during the postlegalization period.<\/p>\n<p><strong>Meaning<\/strong> These findings suggest that the association between cannabis use disorders and <i>schizophrenia<\/i> is an important consideration for the legalization of cannabis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Question Were the liberalization of medical cannabis and the legalization of nonmedical cannabis in Canada associated with changes in the population-attributable fraction of cannabis use disorders associated with schizophrenia? Findings In this population-based cohort study comprising 13 588 681 individuals, the population-attributable fraction of cannabis use disorder associated with schizophrenia increased significantly from 3.7% in [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1496,47],"tags":[],"class_list":["post-205568","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-law","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/205568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=205568"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/205568\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=205568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=205568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=205568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}